Keyphrases
Behavior Change
100%
Malignant Melanoma
100%
Interleukin-2
100%
Immune Alterations
100%
Neuroendocrine-immune System
100%
Escitalopram
100%
Neuroendocrine Differentiation
100%
Depressive Symptoms
40%
Interleukin-6
30%
Cortisol
20%
Placebo
20%
Antidepressants
20%
Hamilton Depression Rating Scale (HAM-D)
20%
Neurobehavioral Development
20%
National Institutes of Health
10%
Temporal Trends
10%
Aging Effect
10%
Generalized Estimating Equations
10%
Clinically Significant
10%
Small Sample Size
10%
Treatment Effect
10%
2-dose
10%
4-cycle
10%
Large Sample Size
10%
Plasma Cortisol
10%
T-cell Cytokines
10%
Selective Serotonin Reuptake Inhibitors
10%
Immune Activation
10%
3-point
10%
Concomitant Medications
10%
Medicine and Dentistry
Behavioral Change
100%
Interleukin 2
100%
Immunity
100%
Escitalopram
100%
Melanoma
100%
Corticotropin
40%
Depressive Disorder
40%
Interleukin 6
30%
Hydrocortisone
30%
Placebo
20%
Hamilton Rating Scale for Depression
20%
Antidepressant
20%
T Cell
10%
Cytokine
10%
Serotonin
10%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Interleukin 2
100%
Escitalopram
100%
Corticotropin
40%
Depressive Disorder
40%
Hydrocortisone
30%
Interleukin 6
30%
Placebo
20%
Antidepressant
20%
Cytokine
10%
Neuroscience
Interleukin 2
100%
Escitalopram
100%
Blood Plasma
50%
Adrenocorticotropic Hormone
40%
Depressive Disorder
40%
Cortisol
30%
Interleukin 6
30%
Placebo
20%
Antidepressant
20%
Hamilton Rating Scale for Depression
20%
T Cell
10%